China’s WuXi Biologics moving big in Singapore
China’ s WuXi Biologics has introduced a 10-year purchase plan aimed at creating a world-class pharmaceutic contract manufacturing center in Singapore. The Singapore Economic Development Board (EDB) can be supporting the project. EDB Chairman Dr Beh Swan Gin stated that “The investments will set up Singapore as a substantial node in the company’s global research, growth and manufacturing […]
The posting China’ s WuXi Biologics moving big in Singapore appeared first on Asia Times .